TheEdgeResearch
Home / Stocks / AFIB

Acutus Medical, Inc. (AFIB)

OTC Healthcare Medical - Devices
$0.00 ▲ +100.00%
Market Cap
$5,982
Sector
Healthcare
Industry
Medical - Devices
Beta
5.76
52-Wk Range
0.0001-0.014
CEO
Takeo Mukai
Country
US
Currency
USD

Acutus Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlsbad, CA, US. The stock last traded at $0.00, up 100.00% on the session, giving a market capitalisation of $5,982. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -47.4%. Its beta of 5.76 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
9.67
Gross margin
5.0%
Operating margin
-0.3%
Net margin
-47.4%
Return on equity
Debt / equity
-3.09
Current ratio
2.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
85
IPO date
2020-08-06
Headquarters
Carlsbad, CA, US
About Acutus Medical, Inc.

Acutus Medical, Inc. is a company dedicated to the treatment of cardiac arrhythmias, focusing on the design, manufacturing, and commercialization of specialized tools for catheter-based ablation procedures. These solutions are utilized to manage a spectrum of heart rhythm disorders across both domestic U.S. and international markets. The firm's extensive product offerings include innovative access sheaths, transseptal crossing devices, diagnostic and mapping catheters, along with both traditional and contact-force ablation catheters. It also provides advanced mapping and imaging consoles, accompanying accessories, and vital supporting algorithms and software. Acutus Medical, Inc. was established in 2011 and is headquartered in Carlsbad, California.

Comparable companies

Acutus Medical, Inc. is most often compared with the following Healthcare names:

ARDSCGHCEVLOICCTIGNTINFIQLFPISWNMTCLIFWPHM
More research on AFIB
AFIB technical analysis AFIB TheEdge Score Compare against peers
Open full interactive analysis & DCF →